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Salmonella infections acquired in other
countries are frequently diagnosed in travelers
recently returned to the United States. Al-
though transmission of these infections to other
humans may be rare in the United States,
human-to-bovine transmission may occur
regularly: thousands of cases of bovine Taenia
saginata cysticercosis occurred immediately
before and during the dissemination of MR-
DT104. As humans are the only definitive host
of the T. saginata tapeworm, these cases
confirm the large-scale occurrence of human-to-
animal transmission of enteropathogenic agents
in the United States. Since transmission of
S. Typhimurium from herd to herd is common
in the United States, increased emphasis on
Salmonella infection control may be an effective
method for reducing dissemination of organ-
isms such as MR-DT104.
With or without imposition of stringent
controls on antibiotic use in the United States
and Europe, the future genetic emergence of
new epidemic clones of S. Typhimurium some-
where in the world is highly likely, and control-
ling the dissemination of epidemic clones is
essential to avoid increasing problems with
multidrug resistance. Certainly we do not
disagree with the concept of reducing antimi-
crobial use, particularly such frivolous use as in
calf milk replacers. However, we urge public
health officials to consider that infection control
is as central to control of agents such as MR-
DT104 as it is for epidemic MRSA.
Margaret A. Davis, Dale D. Hancock,
Thomas E. Besser, Daniel H. Rice, John M. Gay
Washington State University, Pullman,
Washington, USA
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Malaria and Global Warming in
Perspective?
To the Editor: The two reports from the Inter-
national Panel on Climate Change (IPCC) (1,2)
cited in the letter by Pim Martens (3) are
widely regarded as “the standard scientific
reference for all concerned with climate change
and its consequences,” yet the contents of these
reports are often misleading. The quoted
passage does not acknowledge the devastation
caused by malaria in temperate regions. The
reassurance that “existing public health re-
sources” would “make reemergent malaria
unlikely” ignores the nonclimatic factors that
led to its disappearance and continued absence.
Moreover, although malaria/climate models are
not meant to predict future worlds, the IPCC
chapter (1) on human health—one-third of
which is devoted to vector-borne disease—
makes extensive use of such models to warn of
substantial “actual climate-related increases in
malaria incidence” and “highly likely” exten-Letters
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sions of its distribution. The chapter does
include statements that the “predictions” of
such models should be viewed cautiously “until
they have been validated against historical data
sets,” and “malaria is most likely to extend its
spread…in tropical countries.” The past pres-
ence of malaria in “southern Europe” is also
mentioned, but such qualifiers are applied to
predictions of 10- to 100-fold increases in
epidemic potential in temperate climates. These
predictions are frequently cited as evidence of a
major threat to humanity (4,5).
The IPCC reports state “…anopheline
mosquito species that transmit malaria do not
usually survive where the mean winter tem-
perature drops below 16°-18°C.” Similarly, two
oft-quoted publications (6,7) define the vector’s
limit of survival as the 15°C winter isotherm,
i.e., in the northern Sahara. However, in the
past the limit was the 15°C summer isotherm.
In fact, much of Europe and all of the United
States are within the 20°C or 25°C summer
isotherms, and malaria was once prevalent in
parts of southern Canada and up to 64°N in
Russia and Siberia. The same publications state
that Aedes aegypti, the principal urban vector of
dengue and yellow fever, cannot survive mean
temperatures below 10°C, but with global
warming “…dengue could extend into the
southern United States.” This statement has
been repeatedly quoted (5), although Ae. aegypti
is common where winter temperatures of -15°C
are not unusual and epidemics of dengue and
yellow fever have occurred as far north as
Boston and Dublin. Repeated claims that global
warming may have already led to increases in
these diseases in the tropics are equally inde-
fensible (8,9).
Paul Reiter
Centers for Disease Control and Prevention, San
Juan, Puerto Rico, USA
References
  1. Intergovernmental Panel on Climate Change (IPCC).
Impacts, adaptations and mitigation of climate
change: scientific-technical analyses. Watson RT,
Zinyowera MC, Moss RH, editors. New York:
Cambridge University Press;1996. Chapter 18.
  2. Intergovernmental Panel on Climate Change. The
regional impacts of climate change: an assessment of
vulnerability. Working Group II. Intergovernmental
Panel on Climate Change. New York: Cambridge
University Press; 1998. Chapters 5,8.
  3. Martens P. Malaria and global warming in
perspective? [letter] Emerg Infect Dis 2000;6:313-4.
  4. Ross A. Strange weather: culture, science and
technology in the age of limits. London: Verso; 1996.
  5. Gelbspan R. The heat is on: the high stakes battle
over Earth’s threatened climate. New York: Addison-
Wesley; 1997.
  6. Patz JA, Epstein PR, Burke TA, Balbus JM. Global
climate change and emerging infectious diseases.
JAMA 1996;275:217-23.
  7. Epstein PR, Diaz HF, Elias S, Grabherr G, Graham
NE, Martens WJM, et al. Biological and physical
signs of climate change: focus on mosquito-borne
diseases. Bulletin of the American Meteorological
Society 1998;79:409-17.
  8. Reiter P. Global warming and vector-borne disease in
temperate regions and at high altitude. Lancet
1998;351:839-40.
  9. Mouchet J, Manguin S, Sircoulon J, Laventure S,
Faye O, Onapa AW, et al. Evolution of malaria in
Africa for the past 40 years: impact of climatic and
human factors. J Am Mosq Control Assoc
1998;14:121-30.